These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37956925)

  • 1. Size-tunable nanogels for cascaded release of metronidazole and chemotherapeutic agents to combat Fusobacterium nucleatum-infected colorectal cancer.
    Xie S; Wei L; Liu Y; Meng J; Cao W; Qiu B; Li X
    J Control Release; 2024 Jan; 365():16-28. PubMed ID: 37956925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene delivery system with autophagy blockade for enhanced anti-angiogenic therapy against Fusobacterium nucleatum-associated colorectal cancer.
    Li N; Yu Y; Chen Q; Niu J; Gao C; Qu X; Zhang J; Gao H
    Acta Biomater; 2024 Jul; 183():278-291. PubMed ID: 38838905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial tellurium-containing polycarbonate drug carriers to eliminate intratumor bacteria for synergetic chemotherapy against colorectal cancer.
    Hu J; Ran S; Huang Z; Liu Y; Hu H; Zhou Y; Ding X; Yin J; Zhang Y
    Acta Biomater; 2024 Jul; ():. PubMed ID: 38964527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electro-antibacterial therapy (EAT) to enhance intracellular bacteria clearance in pancreatic cancer cells.
    Duncan JL; Ahmad RN; Danesi H; Slade DJ; Davalos RV; Verbridge SS
    Bioelectrochemistry; 2024 Jun; 157():108669. PubMed ID: 38377890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy.
    Xu F; Zhu J; Lin L; Zhang C; Sun W; Fan Y; Yin F; van Hest JCM; Wang H; Du L; Shi X
    Theranostics; 2020; 10(10):4349-4358. PubMed ID: 32292499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive nanogels with ortho ester linkages prepared via thiol-ene click chemistry for efficient intracellular drug release.
    Wang J; Wang X; Yan G; Fu S; Tang R
    J Colloid Interface Sci; 2017 Dec; 508():282-290. PubMed ID: 28843107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remotely Controllable Supramolecular Nanomedicine for Drug-Resistant Colorectal Cancer Therapy Caused by Fusobacterium nucleatum.
    Yan X; Xin Y; Yu Y; Li X; Li B; Elsabahy M; Zhang J; Ma F; Gao H
    Small Methods; 2024 Mar; 8(3):e2301309. PubMed ID: 38018349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeted and nitric oxide-generated nanogels of keratin and hyaluronan for enhanced cancer therapy.
    Sun Z; Yi Z; Cui X; Chen X; Su W; Ren X; Li X
    Nanoscale; 2018 Jul; 10(25):12109-12122. PubMed ID: 29915821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bio-responsive alginate-keratin composite nanogels with enhanced drug loading efficiency for cancer therapy.
    Sun Z; Yi Z; Zhang H; Ma X; Su W; Sun X; Li X
    Carbohydr Polym; 2017 Nov; 175():159-169. PubMed ID: 28917852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer.
    Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H
    Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
    Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
    Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
    Chen L; Zhao R; Kang Z; Cao Z; Liu N; Shen J; Wang C; Pan F; Zhou X; Liu Z; Yang Y; Chen Q
    J Control Release; 2023 Nov; 363():43-56. PubMed ID: 37734673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Responsive Nanogels with Cascaded Gentamicin Release and Lysosomal Escape to Combat Intracellular Small Colony Variants for Peritonitis and Sepsis Therapies.
    Xie S; Li Y; Cao W; Peng J; Huang K; Meng J; Li X
    Adv Healthc Mater; 2024 Jun; 13(14):e2303671. PubMed ID: 38416744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Responsive poly(vinyl caprolactam)-Based Nanogels for Tunable Intracellular Doxorubicin Delivery in Cancer Cells.
    Rao KM; Suneetha M; Kumar DV; Kim HJ; Seok YJ; Han SS
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium nucleatum carcinogenesis and drug delivery interventions.
    Chen Z; Huang L
    Adv Drug Deliv Rev; 2024 Jun; 209():115319. PubMed ID: 38643839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral
    Geng S; Guo P; Li X; Shi Y; Wang J; Cao M; Zhang Y; Zhang K; Li A; Song H; Zhang Z; Shi J; Liu J; Yang Y
    ACS Nano; 2024 Mar; 18(12):8971-8987. PubMed ID: 38497600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release.
    Yang H; Wang Q; Huang S; Xiao A; Li F; Gan L; Yang X
    ACS Appl Mater Interfaces; 2016 Mar; 8(12):7729-38. PubMed ID: 26960600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-triggered- and tumor-targeted delivery with tunable, methacrylated poly(ethylene glycols) and hyaluronic acid hybrid nanogels.
    Liwinska W; Waleka-Bagiel E; Stojek Z; Karbarz M; Zabost E
    Drug Deliv; 2022 Dec; 29(1):2561-2578. PubMed ID: 35938558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.